DiaSorin completes EUR 250 million buyback and DiaSorin stock costs EUR 77.84

DiaSorin (ISIN IT0003492391) completed a EUR 250 million share buyback on October 7, 2026, according to Emarketstorage. The stock was at EUR 77.84 at Lang & Schwarz on October 12, 2026 at 10:18 a.m. CEST, while the Xetra reference base produced a plus 0.54 percent calculation.

Buyback reaches EUR 250 million

The program covered 3,790,952 treasury shares, equal to 6.78 percent of the share capital, with total spending of EUR 249,999,986.67. The filing said DiaSorin held 6,683,050 treasury shares after the purchases, equal to 11.95 percent of the share capital on October 5, 2026.

The buyback was intended to cancel the acquired shares without reducing share capital. That makes the 6.78 percent program size the central ownership figure, while the 11.95 percent total treasury-share position includes shares already held.

What do the results show?

According to Yahoo Finance, revenue reached EUR 602 million in the first half of 2026 and was flat at constant exchange rates versus the first half of 2025. Second-quarter revenue grew 4 percent at constant exchange rates, giving the company a stronger comparison point inside the half-year period.

First-half EBITDA was EUR 194 million, down 7 percent at constant exchange rates, while the EBITDA margin was 32 percent. Management confirmed 2026 guidance for revenue growth of 5-6 percent and an adjusted EBITDA margin of 32-33 percent.

Three dated company milestones

On July 31, 2026, DiaSorin reported EUR 602 million of first-half revenue and EUR 194 million of EBITDA through its earnings call. On October 2, 2026, Margherita Sacerdoti joined as Investor Relations and ESG Senior Director after more than 15 years in investor relations, as GenomeWeb reported.

On October 7, 2026, the company completed the EUR 250 million buyback, the latest of the three dated milestones. The sequence moves from operating performance to investor-relations leadership and then to capital allocation.

Upcoming reporting dates

The published calendar lists November 6, 2026, for third-quarter 2026 results, with an estimated earnings per share figure of EUR 0.93, according to Finanzen.net. The same calendar lists March 12, 2027, for fourth-quarter 2026 results.

Stock remains below yearly high

DiaSorin was trading at EUR 77.84 at Lang & Schwarz on October 12, 2026 at 10:18 a.m. CEST. That was plus 0.54 percent versus the Xetra close of October 9, 2026 at EUR 77.42, leaving the price below the EUR 79.72 52-week high and above the EUR 52.34 low.

The further course of trading is shown by the continuously updated real-time quote of DiaSorin stock.

Market context: Market report FTSE MIB.

More news and analyses on DiaSorin stock